Referências

  1. Portincasa P, Di Ciaula A, Bonfrate L, et al. (2023). Metabolic Dysfunction-Associated Gallstone Disease: Expecting More From Critical Care Manifestations. Internal and Emergency Medicine, 18(7), 1897-1918. doi:10.1007/s11739-023-03355-z.
  2. EASL Clinical Practice Guidelines on the Prevention, Diagnosis and Treatment of Gallstones. (2016). Journal of Hepatology, 65(1), 146-181. doi:10.1016/j.jhep.2016.03.005.
  3. Roda E, Aldini R, Bazzoli F, et al. (1992). Pathophysiology and Pharmacotherapy of Cholelithiasis. Pharmacology & Therapeutics, 53(2), 167-185. doi:10.1016/0163-7258(92)90007-m.
  4. Shabanzadeh DM, Christensen DW, Ewertsen C, et al. (2022). National Clinical Practice Guidelines for the Treatment of Symptomatic Gallstone Disease: 2021 Recommendations From the Danish Surgical Society. Scandinavian Journal of Surgery: SJS: Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 111(3), 11-30. doi:10.1177/14574969221111027.
Tópico anterior
Back to Lição
Próximo Questionário